Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis

Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls

(2015) Erik Pålsson et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Age-dependent decreases of high energy phosphates in cerebral gray matter of patients with bipolar I disorder: A preliminary phosphorus-31 magnetic resonance spectroscopic imaging study

(2015) Jonathan A. Dudley et al.   JOURNAL OF AFFECTIVE DISORDERS

Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder

(2014) Rafael T de Sousa et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients

(2014) Joel Jakobsson et al.   NEUROPSYCHOPHARMACOLOGY

Effect of sleep deprivation on the human metabolome

(2014) S. K. Davies et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study

(2014) S Koike et al.   Translational Psychiatry

Cost of illness for bipolar disorder: a systematic review of the economic burden

(2013) Katja Kleine-Budde et al.   BIPOLAR DISORDERS

The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment

(2013) Ana C. Andreazza et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Isocitrate dehydrogenase mutations in leukemia

(2013) Anna Sophia McKenney et al.   JOURNAL OF CLINICAL INVESTIGATION

Genetics of bipolar disorder

(2013) Nick Craddock et al.   LANCET

Altered Metabolites in the Plasma of Autism Spectrum Disorder: A Capillary Electrophoresis Time-of-Flight Mass Spectroscopy Study

(2013) Hitoshi Kuwabara et al.   PLoS One

The societal cost of bipolar disorder in Sweden

(2013) Mattias Ekman et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities

(2013) R. A. Cairns et al.   Cancer Discovery

Comorbidities and Mortality in Bipolar Disorder

(2013) Casey Crump et al.   JAMA Psychiatry

International validation of the out-of-hospital cardiac arrest score in the United States*

(2011) Sabina Hunziker et al.   CRITICAL CARE MEDICINE

Mitochondria, oligodendrocytes and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosis

(2011) Christine Konradi et al.   NEUROBIOLOGY OF DISEASE

Manic episodes are associated with grey matter volume reduction - a voxel-based morphometry brain analysis

(2010) C. J. Ekman et al.   ACTA PSYCHIATRICA SCANDINAVICA

Mitochondrial Complex I Activity and Oxidative Damage to Mitochondrial Proteins in the Prefrontal Cortex of Patients With Bipolar Disorder

(2010) Ana C. Andreazza et al.   ARCHIVES OF GENERAL PSYCHIATRY

An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009

(2010) Steven C. Dilsaver   JOURNAL OF AFFECTIVE DISORDERS

Metabolomic Profiling of Anionic Metabolites by Capillary Electrophoresis Mass Spectrometry

(2009) Tomoyoshi Soga et al.   ANALYTICAL CHEMISTRY

Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD

(2009) Eleonore Rydén et al.   JOURNAL OF NEURAL TRANSMISSION

Managing bipolar disorders in children and adolescents

(2009) Eric Taylor   Nature Reviews Neurology

Metabolomics tools for identifying biomarkers for neuropsychiatric diseases

(2009) Marlon P. Quinones et al.   NEUROBIOLOGY OF DISEASE

The Stanley Neuropathology Consortium Integrative Database: a Novel, Web-Based Tool for Exploring Neuropathological Markers in Psychiatric Disorders and the Biological Processes Associated with Abnormalities of Those Markers

(2009) Sanghyeon Kim et al.   NEUROPSYCHOPHARMACOLOGY

Postmortem Brain Tissue for Drug Discovery in Psychiatric Research

(2009) S. Kim et al.   SCHIZOPHRENIA BULLETIN

The largest prospective warfarin-treated cohort supports genetic forecasting

(2008) M. Wadelius et al.   BLOOD

Metabolic Phenotyping in Health and Disease

(2008) Elaine Holmes et al.   CELL

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder

(2008) M J Lan et al.   MOLECULAR PSYCHIATRY

Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle

(2008) Dyonne T Hartong et al.   NATURE GENETICS

Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder

(2008) Jorge A Quiroz et al.   NEUROPSYCHOPHARMACOLOGY

Metabolic alterations in medication-free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study

(2008) John D. Port et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Molecular neurobiology of bipolar disorder: a disease of ‘mood-stabilizing neurons’?

(2008) Tadafumi Kato   TRENDS IN NEUROSCIENCES